Loading...
UK Trademark — IPO
SiPore
Application UK00917548314 · Registered
Quick Facts
| Application Number | UK00917548314 |
| Status | Registered |
| Owner | Sigrid Therapeutics AB |
| Filed | 2017-12-01 |
| Registered | 2018-08-10 |
| Renewal Due | 2027-12-01 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Is this trademark active?
Yes. SiPore is currently a registered UK trademark, with renewal due on 2027-12-01. It is protected under UK intellectual property law and can be enforced against infringing uses.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Dietetic preparations adapted for medical use; dietetic substances adapted for medical use; pharmaceuticals and natural remedies; preparations for use in naturopathy; nutritional supplements; chemical preparations for medical purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances, tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances, tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients; not including products primarily for use in the treatment of angina pectoris and high blood pressure.
Class 10 — Medical Devices
Surgical and medical devices; capsulated medical devices; medical devices for the treatment and/or prevention of obesity and being overweight and their related diseases, and/or for use in weight control; medical devices for prediabetes, diabetes and glycaemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients.
Timeline
- Filed: 2017-12-01
- Registered: 2018-08-10
- Renewal due: 2027-12-01
About This Trademark
'SiPore' is a registered trademark on the UK IPO register, owned by Sigrid Therapeutics AB. The application (UK00917548314) was filed on 1 December 2017 and registered on 10 August 2018. The registration is set to expire on 1 December 2027.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus).
The trademark is represented by Potter Clarkson LLP.
Frequently Asked Questions
Who owns UK trademark UK00917548314 ('SiPore')?
UK trademark UK00917548314 for the mark 'SiPore' in Class 5, 10 is recorded on the UK IPO register as owned by Sigrid Therapeutics AB. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is UK trademark UK00917548314 currently a registered trademark?
Yes — the UK IPO records UK trademark UK00917548314 for the mark 'SiPore' as registered.
Which Nice classes is UK trademark UK00917548314 registered under?
UK trademark UK00917548314 for the mark 'SiPore' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus). The filed specification reads: Class 5: Dietetic preparations adapted for medical use; dietetic substances adapted for medical use; pharmaceuticals and natural remedies; preparations for use in naturopathy; nutritional supplements; chemical preparations for medical purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; dietar…
When was UK trademark UK00917548314 filed?
UK trademark UK00917548314 for the mark 'SiPore' was filed at the UK IPO on 1 December 2017 and registered on 10 August 2018.
When does UK trademark UK00917548314 need to be renewed?
UK trademark UK00917548314 for the mark 'SiPore' is currently recorded as valid until 1 December 2027, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00917548314?
Potter Clarkson LLP is listed as the attorney / representative of record for UK trademark UK00917548314 for the mark 'SiPore' on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Cross-Register Filings
Trademarks matching "SiPore" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
US — United States (USPTO)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SIPORESame applicant | 79245402 | 700 | 2018-06-01 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SIPORA | 99634427 | 630 | 2026-02-04 |
| SIPORUI | 99120530 | 686 | 2025-04-04 |
| SIPORAX | 79420173 | 641 | 2025-02-25 |
| SIPOR2 WEIGHT LOSS HELPER | 86938675 | 602 | 2016-03-14 |
Australia — Australia (IP Australia)
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SiPoreSame applicant | 1970761 | protected | 2018-11-15 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SIPOREX | 95204 | ceased | 1948-05-19 |
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
United States (USPTO)
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australia (IP Australia)
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.